Table of contents
December 2002 Vol 2 No 12
In this issue
p887 | doi:10.1038/nrc965
Research Highlights
Cancer prevention: Supermice
p889 | doi:10.1038/nrc957
Angiogenesis: Stemming the flow
p890 | doi:10.1038/nrc958
Therapeutics: Breaking down barriers
p890 | doi:10.1038/nrc961
Apoptosis: Escaping the rays
p891 | doi:10.1038/nrc955
Apoptosis: Divide or die
p892 | doi:10.1038/nrc953
Chemotherapeutics: Opposites don't always attract
p892 | doi:1.1038/nrc962
Colorectal Cancer: Know your place
p893 | doi:10.1038/nrc960
Trial Watch
Attack of the clones
p893 | doi:10.1038/nrc963
Tumour suppressors: Women only
p894 | doi:10.1038/nrc954
DNA Repair: Molecular mimicry
p894 | doi:10.1038/nrc956
Web Watch
Getting to the core
p894 | doi:10.1038/nrc964
News in Brief
Therapeutics | Diagnostics | Immunotherapy | Therapeutics
p895 | doi:10.1038/nrc959
Focus on: Early detection
Reviews
Bloodborne biomolecular markers in prostate cancer development and progression
Robert A. Bok & Eric J. Small
p918 | doi:10.1038/nrc951
Reviews
Bloodborne biomolecular markers in prostate cancer development and progression
Robert A. Bok & Eric J. Small
p918 | doi:10.1038/nrc951
Pancreatic cancer biology and genetics
Nabeel Bardeesy & Ronald A. DePinho
p897 | doi:10.1038/nrc949
The retinoblastoma tumour suppressor in development and cancer
Marie Classon & Ed Harlow
p910 | doi:10.1038/nrc950
Molecular mechanisms of novel therapeutic approaches for multiple myeloma
Teru Hideshima & Kenneth C. Anderson
p927 | doi:10.1038/nrc952
Perspectives
Timeline
Polyoma virus middle T antigen and its role in identifying cancer-related molecules
Stephen M. Dilworth
p951 | doi:10.1038/nrc946
Opinion
SV40 and human tumours: myth, association or causality?
Adi F. Gazdar, Janet S. Butel & Michele Carbone
p957 | doi:10.1038/nrc947
Erratum: anti-oestrogenic prevention of breast cancer — the make or break point
Trevor J. Powles
p964 | doi:10.1038/nrc974
